Generic placeholder image

Current Drug Targets

Editor-in-Chief

ISSN (Print): 1389-4501
ISSN (Online): 1873-5592

Nanotools for the Delivery of Antimicrobial Peptides

Author(s): Patricia Urban, Juan Jose Valle-Delgado, Ernest Moles, Joana Marques, Cinta Diez and Xavier Fernandez-Busquets

Volume 13, Issue 9, 2012

Page: [1158 - 1172] Pages: 15

DOI: 10.2174/138945012802002302

Price: $65

conference banner
Abstract

Antimicrobial peptide drugs are increasingly attractive therapeutic agents as their roles in physiopathological processes are being unraveled and because the development of recombinant DNA technology has made them economically affordable in large amounts and high purity. However, due to lack of specificity regarding the target cells, difficulty in attaining them, or reduced half-lives, most current administration methods require high doses. On the other hand, reduced specificity of toxic drugs demands low concentrations to minimize undesirable side-effects, thus incurring the risk of having sublethal amounts which favour the appearance of resistant microbial strains. In this scenario, targeted delivery can fulfill the objective of achieving the intake of total quantities sufficiently low to be innocuous for the patient but that locally are high enough to be lethal for the infectious agent. One of the major advances in recent years has been the size reduction of drug carriers that have dimensions in the nanometer scale and thus are much smaller than —and capable of being internalized by— many types of cells. Among the different types of potential antimicrobial peptide-encapsulating structures reviewed here are liposomes, dendritic polymers, solid core nanoparticles, carbon nanotubes, and DNA cages. These nanoparticulate systems can be functionalized with a plethora of biomolecules providing specificity of binding to particular cell types or locations; as examples of these targeting elements we will present antibodies, DNA aptamers, cellpenetrating peptides, and carbohydrates. Multifunctional Trojan horse-like nanovessels can be engineered by choosing the adequate peptide content, encapsulating structure, and targeting moiety for each particular application.

Keywords: Antibodies, aptamers, dendrimers, liposomes, nanomedicine, nanoparticles, nanovectors, targeting, Antimicrobial peptide, nanovessels


Rights & Permissions Print Cite
© 2024 Bentham Science Publishers | Privacy Policy